The ETF is Not Compliant. The impure income of its holdings is more than 5% of total revenues.
FMED – Fidelity Disruptive Medicine ETF
🔒
Not Compliant
☆☆☆☆☆ 0/5
- Equity
- Equity Sector Healthcare
- ETF
Please log in to manage your watchlist.
Go PRO for ETF Screening
Unlock Industry-grade Shariah Compliance for ETFs. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.
We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.
ETF Screening starts from just $5.99/month
89.02%
Impure Income
-
Zakat per Share*
-
Purification
Debt
11.20%
✓
Non-Compliant Assets
7.24%
✓
Impure Income
89.02%
✗
Debt
12.32%
✓
Impure Income
89.02%
✗
Debt
11.98%
✓
Impure Income
89.02%
✗
Debt
24.40%
✓
Cash
9.54%
✓
Cash & AR
11.71%
✓
Impure Income
89.02%
✗
Debt
24.40%
✓
Cash
9.54%
✓
Cash & AR
11.71%
✓
Impure Income
89.02%
✗
ETF Objective
The Fund seeks long-term growth of capital. The Fund invests in securities of disruptive medicine companies. These companies include those that are engaged in robotic surgery, gene therapy, genomics, rare diseases, medical devices and equipment, immunotherapy, technology-based health care platforms, and consumer wellness.
We do our best to screen stocks as accurately as possible. Please let us know in the Community if you spot an error or find something questionable. Jazaak Allahu khairan.
